This paper is in the following e-collection/theme issue:

Pharmacovigilance (154) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (177) Pharmacology and Pharmaceutics (84) Safety and Error Prevention in Health (221) Depression and Mood Disorders; Suicide Prevention (1490) Intentional Self-Harm (110)

Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49755, first published .
Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review

Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review

Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review

Authors of this article:

Soo Min Jeon1 Author Orcid Image ;   HyunJoo Lim2 Author Orcid Image ;   Hyo-bin Cheon2 Author Orcid Image ;   Juhee Ryu3 Author Orcid Image ;   Jin-Won Kwon4 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
JMIR Publications JMIR Publications @jmirpub

JMIR Public Health: Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review https://t.co/wRb0g7Rgpg https://t.co/xCUI1kRmzD

3:06 PM · Jan 30, 2024

1
1
JMIR Public Health and Surveillance JMIR Public Health and Surveillance @JMIR_PH

RT @jmirpub: JMIR Public Health: Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review https://t.co/w…

3:07 PM · Jan 30, 2024

1
1